Professor of Surgery
OHSU
portland, Oregon, United States
Rodney F. Pommier, M.D. is Professor of Surgery in the Division of Surgical Oncology at Oregon Health & Science University (OHSU) in Portland, Oregon and a consultant in neuroendocrine tumors in the WellNET program at the Wellington Hospital, London, U.K. He is a nationally and internationally recognized expert in the surgical and other treatments of neureondocrine tumors. He graduated from medical school at OHSU and then did his surgical residency at OHSU. He has completed two fellowships in surgical oncology, the first throught he American Cancer Society at OHSU and the second at Memorial Sloan-Kettering Cancer Center in New York. He has had a career long interest in neuroendocrine tumors and was one of only seven investigators, and the only surgeon, that tested octreotide LAR for the treatment of carcinoid syndrome, leading to its FDA approval. He has been an investigator enrolling many patients in many other trials including the RADIANT 1 through 4 trials testing everolimus against various neuroendocrine tumors and lanreotide for control of carcinoid syndrome in the ELECT trial, leading to their FDA approvals. He was a founding member of the North American Neuroendocrine Tumor Society in 2006 and has since served 16 continuous years on its board of directors. He is a member of the United Kingdom and Ireland Neuroendocrine Tumour Society and the European Neuroendocrine Tumor Society. His personal research interests include surgical cytoreduction of hepatic metastases and carcinomatosis for metastatic neuroendocrine tumors, surgical exploration for locating occult primary neuroendocrine tumors, and the pathophysiology and treatment of intraoperative carcinoid crisis. In his spare time, he plays classical piano and observing and photographing the sky from his lback yard astronomical observatory dome. He is a heavily published author of astronomy articles and of his long exposure astrophotographs, which can be viewed at www.rodpommier.com.
QS28. International expert consensus on perioperative management of carcinoid crisis.
Thursday, March 5, 2026
3:45 PM - 3:49 PM MST